The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion

U.S. Insomnia Marke report provides a detailed overview of the major drivers, restraints, challenges, current market trends, and strategies impacting the U.S. insomnia market along with the estimates and forecasts of the revenue.

U.S. Insomnia Market report categories the global market by Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)), Non-Pharmacological Therapy (Hypnotherapy,

U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root))

U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021